Hedge fund billionaire Daniel Loeb slashed his stake in the consumer health company Kenvue Inc. (NYSE:KVUE) at Third Point LLC in the fourth quarter of FY25.

As of Dec. 31, 2025, Loeb reduced his stake in the company by 64% to 3.25 million shares from about 9.0 million shares in the third quarter of 2025.

Notably, Kenvue was formerly a part of Johnson & Johnson (NYSE:JNJ) before becoming an independent company in August 2023. The company's major products include several J&J brands, including Tylenol, Listerine, Neutrogena, and Nicorette.

Recent Key Events

In February, Kenvue reported fourth-quarter earnings of 27 cents per share, which beat the consensus of 22 cents. The company reported sales of $3.780 billion, which exceeded the consensus estimate of $3.681 billion.

The company’s Board approved an initiative to streamline its operating model, which is expected to reduce the workforce by approximately 3.5%. The program is projected to incur pre-tax restructuring ...